Nicholas James Short (Nicholas Short, Naval Daver, Nicholas J Short)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 205

Top Venues

American journal of hematology

Cancer

Blood cancer journal

Blood advances

This page only lists publications with an associated author ORCID identifier.

Publications

Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology 99 (8) (2024)
Rucha V Modak, Katia Graziella de Oliveira Rebola, John McClatchy, Mona Mohammadhosseini, Alisa Damnernsawad, Stephen E Kurtz, Christopher A Eide, Guanming Wu, Ted Laderas, Tamilla Nechiporuk, Marina A Gritsenko, Joshua R Hansen, Chelsea Hutchinson, Sara J C Gosline, Paul D Piehowski, Daniel Bottomly, Nicholas James Short, Karin D Rodland, Shannon K McWeeney, Jeffrey W Tyner, Anupriya Agarwal
Targeting CCL2/CCR2 signaling overcomes MEK inhibitor resistance in Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology 99 (8) (2024)
Nicholas James Short, Elias Jabbour, Nitin Jain, Jayastu Senapati, Lewis Fady Nasr, Fadi G Haddad, Zhenhua Li, Yu-Chih Hsiao, Jun J Yang, Naveen Pemmaraju, Maro Ohanian, William G Wierda, Guillermo Montalban-Bravo, Gautam Borthakur, Lina Han, Lianchun Xiao, Xuelin Huang, Regina Abramova, Min Zhao, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop Kantarjian
A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia. Blood advances 8 (4) (2024)
Rucha V Modak, Katia Graziella de Oliveira Rebola, John McClatchy, Mona Mohammadhosseini, Alisa Damnernsawad, Stephen E Kurtz, Christopher A Eide, Guanming Wu, Ted Laderas, Tamilla Nechiporuk, Marina A Gritsenko, Joshua R Hansen, Chelsea Hutchinson, Sara J C Gosline, Paul D Piehowski, Daniel Bottomly, Nicholas James Short, Karin D Rodland, Shannon K McWeeney, Jeffrey W Tyner, Anupriya Agarwal
Targeting CCL2/CCR2 signaling overcomes MEK inhibitor resistance in Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Branko Cuglievan, Hagop M Kantarjian, Jeffrey E Rubnitz, Todd M Cooper, C Michel Zwaan, Jessica A Pollard, Courtney D D DiNardo, Tapan Mahendra Kadia, Erin M Guest, Nicholas James Short, David C McCall, Naval G Daver, Cesar Nunez, Fadi G Haddad, Miriam B Garcia, Kapil N Bhalla, Abhishek Maiti, Samanta Catueno, Warren C Fiskus, Bing Z Carter, Amber Gibson, Michael Roth, Sajad Khazal, Priti Tewari, Hussein A Abbas, Wallace Bourgeois, Michael Andreeff, Neerav N Shukla, Danh D Truong, Jeremy Connors, Joseph A Ludwig, Janine Stutterheim, Elisabeth Salzer, Kristian L Juul-Dam, Koiji Sasaki, Kris M Mahadeo, Sarah K Tasian, Gautam Borthakur, Samantha Dickson, Nitin Jain, Elias J Jabbour, Soheil Meshinchi, Guillermo Garcia Manero, Farhad Ravandi, Eytan M Stein, E Anders Kolb, Ghayas C Issa
Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community. Leukemia (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology 99 (5) (2024)
Fady Gh Haddad, Koiji Sasaki, Jayastu Senapati, Lianchun Xiao, Grace S Hwang, Tareq Abuasab, Sangeetha Venugopal, Daniel Rivera, Alexandre Bazinet, Rodrick Babakhanlou, Kunhwa Kim, Faustine Ong, Sai Desikan, Naveen Pemmaraju, Sanam Loghavi, Gautam Borthakur, Courtney DiNardo, Hussein A Abbas, Nicholas James Short, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Outcomes of Patients With Newly Diagnosed AML and Hyperleukocytosis. JCO oncology practice (2024)
Rucha V Modak, Katia Graziella de Oliveira Rebola, John McClatchy, Mona Mohammadhosseini, Alisa Damnernsawad, Stephen E Kurtz, Christopher A Eide, Guanming Wu, Ted Laderas, Tamilla Nechiporuk, Marina A Gritsenko, Joshua R Hansen, Chelsea Hutchinson, Sara J C Gosline, Paul D Piehowski, Daniel Bottomly, Nicholas James Short, Karin D Rodland, Shannon K McWeeney, Jeffrey W Tyner, Anupriya Agarwal
Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Rucha V Modak, Katia Graziella de Oliveira Rebola, John McClatchy, Mona Mohammadhosseini, Alisa Damnernsawad, Stephen E Kurtz, Christopher A Eide, Guanming Wu, Ted Laderas, Tamilla Nechiporuk, Marina A Gritsenko, Joshua R Hansen, Chelsea Hutchinson, Sara J C Gosline, Paul D Piehowski, Daniel Bottomly, Nicholas James Short, Karin D Rodland, Shannon K McWeeney, Jeffrey W Tyner, Anupriya Agarwal
Targeting CCL2/CCR2 signaling overcomes MEK inhibitor resistance in Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Alex Bataller, Alexandre Bazinet, Courtney D D DiNardo, Abhishek Maiti, Gautam Borthakur, Naval G Daver, Nicholas James Short, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Yilmaz, Guillermo Montalban Bravo, Koichi Takahashi, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax. Blood advances 8 (4) (2024)
Hagop M Kantarjian, Nicholas James Short, Fady Gh Haddad, Nitin Jain, Xuelin Huang, Guillermo Montalban-Bravo, Rashmi Kanagal-Shamana, Tapan Mahendra Kadia, Naval G Daver, Kelly Sharon Chien, Yesid Alvarado, Guillermo Garcia Manero, Ghayas C Issa, Rebecca Garris, Cedric Nasnas, Lewis Fady Nasr, Farhad Ravandi, Elias J Jabbour
Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Tareq Abuasab, Gautam Borthakur, Rashmi Kanagal-Shamana, Lucia Masarova, Keyur Patel, Koichi Takahashi, Prithviraj Bose, John Villarreal, Sherry Pierce, Tapan Mahendra Kadia, Guillermo Garcia Manero, Nicholas James Short, Courtney D D DiNardo, Naval G Daver, Farhad Ravandi, Hagop M Kantarjian, Srdan Verstovsek, Musa Ylimaz
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications. American journal of hematology 99 (7) (2024)
Jayastu Senapati, Elias J Jabbour, Nicholas James Short, Nitin Jain, Fady Gh Haddad, Tharakeswara Bathala, Iuliia Kovalenko, Aram Bidikian, Farhad Ravandi, Issa Khouri, Tapan Mahendra Kadia, Rebecca Garris, Guillermo Montalban Bravo, Kelly Chien, Elizabeth Shpall, Partow Kebriaei, Hagop M Kantarjian
Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin. Blood cancer journal 14 (1) (2024)
Alex Bataller, Courtney D D DiNardo, Alexandre Bazinet, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Nicholas James Short, Koiji Sasaki, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Ylimaz, Guillermo Montalban Bravo, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups. American journal of hematology (2024)
Jayastu Senapati, Hagop M Kantarjian, Alexandre Bazinet, Patrick K Reville, Nicholas James Short, Naval G Daver, Gautam Borthakur, Alex Bataller, Elias J Jabbour, Courtney D D DiNardo, Fady Gh Haddad, Koiji Sasaki, Uday R Popat, Betül Oran, Amin M Alousi, Sanam Loghavi, Elizabeth Shpall, Guillermo Garcia Manero, Farhad Ravandi, Tapan Mahendra Kadia
Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantation. Cancer (2024)
Nicholas James Short, Elias J Jabbour, Lewis Fady Nasr, Nitin Jain, Fady Gh Haddad, Ghayas C Issa, Koiji Sasaki, Jayastu Senapati, Partow Kebriaei, Rebecca Garris, Marina Y Konopleva, Farhad Ravandi, Hagop M Kantarjian
Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American journal of hematology 99 (7) (2024)
Guillermo Montalban Bravo, Juan Jose Rodriguez-Sevilla, David Michael Swanson, Rashmi Kanagal-Shamana, Danielle Hammond, Kelly Sharon Chien, Koiji Sasaki, Elias J Jabbour, Courtney D D DiNardo, Koichi Takahashi, Nicholas James Short, Ghayas C Issa, Naveen Pemmaraju, Tapan Mahendra Kadia, Farhad Ravandi, Naval G Daver, Gautam Borthakur, Sanam Loghavi, Sherry Pierce, Carlos Bueso-Ramos, Hagop M Kantarjian, Guillermo Garcia Manero
Influence of co-mutational patterns in disease phenotype and clinical outcomes of chronic myelomonocytic leukemia. Leukemia 38 (5) (2024)
Alex Bataller, Alexandre Bazinet, Courtney D D DiNardo, Abhishek Maiti, Gautam Borthakur, Naval G Daver, Nicholas James Short, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Yilmaz, Guillermo Montalban Bravo, Koichi Takahashi, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax. Blood advances 8 (4) (2024)
Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology 99 (8) (2024)
Nicholas James Short, Elias J Jabbour, Nitin Jain, Jayastu Senapati, Lewis Fady Nasr, Fadi G Haddad, Zhenhua Li, Yu-Chih Hsiao, Jun J Yang, Naveen Pemmaraju, Maro Ohanian, William G Wierda, Guillermo Montalban-Bravo, Gautam Borthakur, Lina Han, Lianchun Xiao, Xuelin Huang, Regina Abramova, Min Zhao, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop M Kantarjian
A Phase 1/2 Study of Mini-Hyper-CVD plus Venetoclax in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia. Blood advances (2024)
Nicholas James Short, Elias J Jabbour, Lewis Fady Nasr, Nitin Jain, Fady Gh Haddad, Ghayas C Issa, Koiji Sasaki, Jayastu Senapati, Partow Kebriaei, Rebecca Garris, Marina Y Konopleva, Farhad Ravandi, Hagop M Kantarjian
Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American journal of hematology (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology 99 (5) (2024)
Yaqi Zhao, Nicholas James Short, Hagop M Kantarjian, Ti-Cheng Chang, Pankaj S Ghate, Chunxu Qu, Walid Macaron, Nitin Jain, Beenu Thakral, Aaron H Phillips, Joseph D Khoury, Guillermo Garcia-Manero, Wenchao Zhang, Yiping Fan, Hui Yang, Rebecca S Garris, Lewis Fady Nasr, Richard W Kriwacki, Kathryn G Roberts, Marina Y Konopleva, Elias J Jabbour, Charles G Mullighan
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL. Blood 144 (1) (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology 99 (5) (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology (2024)
Jayastu Senapati, Elias J Jabbour, Nicholas James Short, Nitin Jain, Fady Gh Haddad, Tharakeswara Bathala, Iuliia Kovalenko, Aram Bidikian, Farhad Ravandi, Issa Khouri, Tapan Mahendra Kadia, Rebecca Garris, Guillermo Montalban Bravo, Kelly Chien, Elizabeth Shpall, Partow Kebriaei, Hagop M Kantarjian
Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin. Blood cancer journal 14 (1) (2024)
Nicholas James Short, Naval G Daver, Courtney D D DiNardo, Tapan Mahendra Kadia, Lewis Fady Nasr, Walid Macaron, Musa Yilmaz, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia Manero, Ghayas C Issa, Kelly Sharon Chien, Elias J Jabbour, Cedric Nasnas, Xuelin Huang, Wei Qiao, Jairo Matthews, Christopher J Stojanik, Keyur Pravinchandra Patel, Regina Abramova, Jennifer Thankachan, Marina Y Konopleva, Hagop M Kantarjian, Farhad Ravandi
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3 -Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology 99 (5) (2024)
Wei-Ying Jen, Hagop M Kantarjian, Tapan Mahendra Kadia, Courtney D D DiNardo, Ghayas C Issa, Nicholas James Short, Musa Ylimaz, Gautam Borthakur, Farhad Ravandi, Naval G Daver
Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease. British journal of haematology 205 (1) (2024)
Yaqi Zhao, Nicholas James Short, Hagop M Kantarjian, Ti-Cheng Chang, Pankaj S Ghate, Chunxu Qu, Walid Macaron, Nitin Jain, Beenu Thakral, Aaron H Phillips, Joseph D Khoury, Guillermo Garcia-Manero, Wenchao Zhang, Yiping Fan, Hui Yang, Rebecca S Garris, Lewis Fady Nasr, Richard W Kriwacki, Kathryn G Roberts, Marina Y Konopleva, Elias J Jabbour, Charles G Mullighan
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL. Blood 144 (1) (2024)
Rucha V Modak, Katia Graziella de Oliveira Rebola, John McClatchy, Mona Mohammadhosseini, Alisa Damnernsawad, Stephen E Kurtz, Christopher A Eide, Guanming Wu, Ted Laderas, Tamilla Nechiporuk, Marina A Gritsenko, Joshua R Hansen, Chelsea Hutchinson, Sara J C Gosline, Paul D Piehowski, Daniel Bottomly, Nicholas James Short, Karin D Rodland, Shannon K McWeeney, Jeffrey W Tyner, Anupriya Agarwal
Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Fady Gh Haddad, Koiji Sasaki, Lewis Fady Nasr, Nicholas James Short, Tapan Mahendra Kadia, Sara Dellasala, Jorge Cortes, Franck Emmanuel Nicolini, Ghayas C Issa, Elias J Jabbour, Hagop M Kantarjian
Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase. Cancer 130 (19) (2024)
Alex Bataller, Courtney D D DiNardo, Alexandre Bazinet, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Nicholas James Short, Koiji Sasaki, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Ylimaz, Guillermo Montalban Bravo, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups. American journal of hematology 99 (4) (2024)
Wei-Ying Jen, Elias J Jabbour, Nicholas James Short, Ghayas C Issa, Fady Gh Haddad, Nitin Jain, Naveen Pemmaraju, Naval G Daver, Lucia Masarova, Gautam Borthakur, Kelly Sharon Chien, Rebecca Garris, Hagop M Kantarjian
A phase 2 trial of mini-hyper-CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia. American journal of hematology (2024)
Rucha V Modak, Katia Graziella de Oliveira Rebola, John McClatchy, Mona Mohammadhosseini, Alisa Damnernsawad, Stephen E Kurtz, Christopher A Eide, Guanming Wu, Ted Laderas, Tamilla Nechiporuk, Marina A Gritsenko, Joshua R Hansen, Chelsea Hutchinson, Sara J C Gosline, Paul D Piehowski, Daniel Bottomly, Nicholas James Short, Karin D Rodland, Shannon K McWeeney, Jeffrey W Tyner, Anupriya Agarwal
Targeting CCL2/CCR2 signaling overcomes MEK inhibitor resistance in Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Wei-Ying Jen, Hagop M Kantarjian, Tapan Mahendra Kadia, Courtney D D DiNardo, Ghayas C Issa, Nicholas James Short, Musa Ylimaz, Gautam Borthakur, Farhad Ravandi, Naval G Daver
Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease. British journal of haematology (2024)
Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology (2024)
Tareq Abuasab, Gautam Borthakur, Rashmi Kanagal-Shamana, Lucia Masarova, Keyur Patel, Koichi Takahashi, Prithviraj Bose, John Villarreal, Sherry Pierce, Tapan Mahendra Kadia, Guillermo Garcia Manero, Nicholas James Short, Courtney D D DiNardo, Naval G Daver, Farhad Ravandi, Hagop M Kantarjian, Srdan Verstovsek, Musa Ylimaz
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications. American journal of hematology 99 (7) (2024)
Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology 99 (8) (2024)
Georgina Gener-Ricos, Alex Bataller, Juan Jose Rodriguez-Sevilla, Kelly Sharon Chien, Andres E Quesada, Emmanuel Almanza-Huante, Danielle Hammond, Koiji Sasaki, Courtney D D DiNardo, Tapan Mahendra Kadia, Naval G Daver, Gautam Borthakur, Ghayas C Issa, Nicholas James Short, Rashmi Kanagal-Shamana, Hagop M Kantarjian, Guillermo Garcia Manero, Guillermo Montalban Bravo
NPM1-mutated myeloid neoplasms are a unique entity not defined by bone marrow blast percentage. Cancer (2024)
Yaqi Zhao, Nicholas James Short, Hagop M Kantarjian, Ti-Cheng Chang, Pankaj S Ghate, Chunxu Qu, Walid Macaron, Nitin Jain, Beenu Thakral, Aaron Phillips, Joseph D Khoury, Guillermo Garcia-Manero, Wenchao Zhang, Yiping Fan, Hui Yang, Rebecca Garris, Lewis Fady Nasr, Richard Kriwacki, Kathryn G Roberts, Marina Y Konopleva, Elias J Jabbour, Charles G Mullighan
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL. Blood (2024)
Tareq Abuasab, Gautam Borthakur, Rashmi Kanagal-Shamana, Lucia Masarova, Keyur Patel, Koichi Takahashi, Prithviraj Bose, John Villarreal, Sherry Pierce, Tapan Mahendra Kadia, Guillermo Garcia Manero, Nicholas James Short, Courtney D D DiNardo, Naval G Daver, Farhad Ravandi, Hagop M Kantarjian, Srdan Verstovsek, Musa Ylimaz
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications. American journal of hematology (2024)
Alex Bataller, Courtney D D DiNardo, Alexandre Bazinet, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Nicholas James Short, Koiji Sasaki, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Ylimaz, Guillermo Montalban Bravo, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups. American journal of hematology 99 (4) (2024)
Nicholas James Short, Elias J Jabbour, Lewis Fady Nasr, Nitin Jain, Fady Gh Haddad, Ghayas C Issa, Koiji Sasaki, Jayastu Senapati, Partow Kebriaei, Rebecca Garris, Marina Y Konopleva, Farhad Ravandi, Hagop M Kantarjian
Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American journal of hematology 99 (7) (2024)
Elias J Jabbour, Fady Gh Haddad, Koiji Sasaki, Bing Z Carter, Yesid Alvarado, Cedric Nasnas, Lewis Fady Nasr, Lucia Masarova, Naval G Daver, Naveen Pemmaraju, Nicholas James Short, Jeffrey Skinner, Tapan Mahendra Kadia, Gautam Borthakur, Guillermo Garcia Manero, Farhad Ravandi, Ghayas C Issa, Michael Andreeff, Hagop M Kantarjian
Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia. Cancer (2024)
Nicholas James Short, Naval G Daver, Courtney D D DiNardo, Tapan Mahendra Kadia, Lewis Fady Nasr, Walid Macaron, Musa Yilmaz, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia Manero, Ghayas C Issa, Kelly Sharon Chien, Elias J Jabbour, Cedric Nasnas, Xuelin Huang, Wei Qiao, Jairo Matthews, Christopher J Stojanik, Keyur Pravinchandra Patel, Regina Abramova, Jennifer Thankachan, Marina Y Konopleva, Hagop M Kantarjian, Farhad Ravandi
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3 -Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Qiudan Shen, Elias J Jabbour, Guillin Tang, Hong Fang, Wei Wang, Nicholas James Short, Mingjian James You, L Jeffrey Medeiros, Shimin Hu
Secondary acquisition of the Philadelphia chromosome in acute lymphoblastic leukemia. American journal of hematology (2024)
Nicholas James Short, Naval G Daver, Courtney D D DiNardo, Tapan Mahendra Kadia, Lewis Fady Nasr, Walid Macaron, Musa Yilmaz, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia Manero, Ghayas C Issa, Kelly Sharon Chien, Elias J Jabbour, Cedric Nasnas, Xuelin Huang, Wei Qiao, Jairo Matthews, Christopher J Stojanik, Keyur Pravinchandra Patel, Regina Abramova, Jennifer Thankachan, Marina Y Konopleva, Hagop M Kantarjian, Farhad Ravandi
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3 -Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Fady Gh Haddad, Koiji Sasaki, Lewis Fady Nasr, Nicholas James Short, Tapan Mahendra Kadia, Sara Dellasala, Jorge Cortes, Franck Emmanuel Nicolini, Ghayas C Issa, Elias J Jabbour, Hagop M Kantarjian
Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase. Cancer (2024)
Alex Bataller, Courtney D D DiNardo, Alexandre Bazinet, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Nicholas James Short, Koiji Sasaki, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Ylimaz, Guillermo Montalban Bravo, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups. American journal of hematology 99 (4) (2024)
Yaqi Zhao, Nicholas James Short, Hagop M Kantarjian, Ti-Cheng Chang, Pankaj S Ghate, Chunxu Qu, Walid Macaron, Nitin Jain, Beenu Thakral, Aaron Phillips, Joseph D Khoury, Guillermo Garcia-Manero, Wenchao Zhang, Yiping Fan, Hui Yang, Rebecca Garris, Lewis Fady Nasr, Richard Kriwacki, Kathryn G Roberts, Marina Y Konopleva, Elias J Jabbour, Charles G Mullighan
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL. Blood (2024)
Rucha V Modak, Katia Graziella de Oliveira Rebola, John McClatchy, Mona Mohammadhosseini, Alisa Damnernsawad, Stephen E Kurtz, Christopher A Eide, Guanming Wu, Ted Laderas, Tamilla Nechiporuk, Marina A Gritsenko, Joshua R Hansen, Chelsea Hutchinson, Sara J C Gosline, Paul D Piehowski, Daniel Bottomly, Nicholas James Short, Karin D Rodland, Shannon K McWeeney, Jeffrey W Tyner, Anupriya Agarwal
Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Hagop M Kantarjian, Gautam Borthakur, Naval G Daver, Courtney D D DiNardo, Ghayas C Issa, Elias J Jabbour, Tapan Mahendra Kadia, Koiji Sasaki, Nicholas James Short, Musa Ylimaz, Farhad Ravandi
Current status and research directions in acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
Wei-Ying Jen, Koiji Sasaki, Sanam Loghavi, Sa A Wang, Wei Qiao, Gautam Borthakur, Farhad Ravandi, Tapan Mahendra Kadia, Ghayas C Issa, Nicholas James Short, Musa Ylimaz, Naval G Daver, Courtney D D DiNardo
Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression. British journal of haematology 204 (6) (2024)
Jayastu Senapati, Elias J Jabbour, Nicholas James Short, Nitin Jain, Fady Gh Haddad, Tharakeswara Bathala, Iuliia Kovalenko, Aram Bidikian, Farhad Ravandi, Issa Khouri, Tapan Mahendra Kadia, Rebecca Garris, Guillermo Montalban Bravo, Kelly Chien, Elizabeth Shpall, Partow Kebriaei, Hagop M Kantarjian
Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin. Blood cancer journal 14 (1) (2024)
Guillermo Montalban Bravo, Juan Jose Rodriguez-Sevilla, David Michael Swanson, Rashmi Kanagal-Shamana, Danielle Hammond, Kelly Sharon Chien, Koiji Sasaki, Elias J Jabbour, Courtney D D DiNardo, Koichi Takahashi, Nicholas James Short, Ghayas C Issa, Naveen Pemmaraju, Tapan Mahendra Kadia, Farhad Ravandi, Naval G Daver, Gautam Borthakur, Sanam Loghavi, Sherry Pierce, Carlos Bueso-Ramos, Hagop M Kantarjian, Guillermo Garcia Manero
Influence of co-mutational patterns in disease phenotype and clinical outcomes of chronic myelomonocytic leukemia. Leukemia (2024)
Elias J Jabbour, Fady Gh Haddad, Koiji Sasaki, Bing Z Carter, Yesid Alvarado, Cedric Nasnas, Lewis Fady Nasr, Lucia Masarova, Naval G Daver, Naveen Pemmaraju, Nicholas James Short, Jeffrey Skinner, Tapan Mahendra Kadia, Gautam Borthakur, Guillermo Garcia Manero, Farhad Ravandi, Ghayas C Issa, Michael Andreeff, Hagop M Kantarjian
Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia. Cancer 130 (15) (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology (2024)
Nicholas James Short, Naval G Daver, Courtney D D DiNardo, Tapan Mahendra Kadia, Lewis Fady Nasr, Walid Macaron, Musa Yilmaz, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia Manero, Ghayas C Issa, Kelly Sharon Chien, Elias J Jabbour, Cedric Nasnas, Xuelin Huang, Wei Qiao, Jairo Matthews, Christopher J Stojanik, Keyur Pravinchandra Patel, Regina Abramova, Jennifer Thankachan, Marina Y Konopleva, Hagop M Kantarjian, Farhad Ravandi
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3 -Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Jayastu Senapati, Hagop M Kantarjian, Alexandre Bazinet, Patrick K Reville, Nicholas James Short, Naval G Daver, Gautam Borthakur, Alex Bataller, Elias J Jabbour, Courtney D D DiNardo, Fady Gh Haddad, Koiji Sasaki, Uday R Popat, Betül Oran, Amin M Alousi, Sanam Loghavi, Elizabeth Shpall, Guillermo Garcia Manero, Farhad Ravandi, Tapan Mahendra Kadia
Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantation. Cancer 130 (19) (2024)
Rucha V Modak, Katia Graziella de Oliveira Rebola, John McClatchy, Mona Mohammadhosseini, Alisa Damnernsawad, Stephen E Kurtz, Christopher A Eide, Guanming Wu, Ted Laderas, Tamilla Nechiporuk, Marina A Gritsenko, Joshua R Hansen, Chelsea Hutchinson, Sara J C Gosline, Paul D Piehowski, Daniel Bottomly, Nicholas James Short, Karin D Rodland, Shannon K McWeeney, Jeffrey W Tyner, Anupriya Agarwal
Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Wei-Ying Jen, Koiji Sasaki, Sanam Loghavi, Sa A Wang, Wei Qiao, Gautam Borthakur, Farhad Ravandi, Tapan Mahendra Kadia, Ghayas C Issa, Nicholas James Short, Musa Ylimaz, Naval G Daver, Courtney D D DiNardo
Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression. British journal of haematology (2024)
Nicholas James Short, Elias Jabbour, Nitin Jain, Jayastu Senapati, Lewis Fady Nasr, Fadi G Haddad, Zhenhua Li, Yu-Chih Hsiao, Jun J Yang, Naveen Pemmaraju, Maro Ohanian, William G Wierda, Guillermo Montalban-Bravo, Gautam Borthakur, Lina Han, Lianchun Xiao, Xuelin Huang, Regina Abramova, Min Zhao, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop Kantarjian
A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia. Blood advances 8 (4) (2024)
Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology 99 (8) (2024)
Koiji Sasaki, Fady Gh Haddad, Nicholas James Short, Nitin Jain, Ghayas Issa, Elias J Jabbour, Hagop M Kantarjian
Outcome of Philadelphia chromosome-positive chronic myeloid leukemia in the United States since the introduction of imatinib therapy-The Surveillance, Epidemiology, and End Results database, 2000-2019. Cancer (2023)
Farhad Ravandi, Asad Bashey, James M Foran, Wendy Stock, Raya Mawad, Nicholas James Short, Musa Ylimaz, Hagop M Kantarjian, Olatoyosi Odenike, Anand Ashwin Patel, Raman Garcha, William Barrett Ainsworth, Raphael Clynes, Jitendra Kanodia, Ying Ding, Huajiang Li, Steve Kye, Alice S Mims
Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia. Blood advances (2023)
Alexandre Bazinet, Tapan M Kadia, Nicholas James Short, Gautam Borthakur, Sa A Wang, Wei Wang, Sanam Loghavi, Jeffrey L Jorgensen, Keyur Pravinchandra Patel, Courtney D D DiNardo, Naval G Daver, Yesid Alvarado, Fadi G Haddad, Sherry R Pierce, Graciela Nogueras Gonzalez, Abhishek Maiti, Koiji Sasaki, Musa Ylimaz, Phillip A Thompson, William G Wierda, Guillermo Garcia-Manero, Michael Andreeff, Elias J Jabbour, Marina Y Konopleva, Xuelin Huang, Hagop M Kantarjian, Farhad Ravandi
Undetectable Measurable Residual Disease is Associated with Improved Outcomes in AML Irrespective of Treatment Intensity. Blood advances (2023)
Aram Bidikian, Elias J Jabbour, Ghayas C Issa, Nicholas James Short, Koiji Sasaki, Hagop M Kantarjian
Chronic Myeloid Leukemia Without Major Molecular Response After 2 Years of Treatment with Tyrosine Kinase Inhibitor. American journal of hematology (2023)
Fady Gh Haddad, Nicholas James Short
Treatment discontinuation in chronic myeloid leukemia: When, how, and why? American journal of hematology (2023)
Hagop M Kantarjian, Nicholas James Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fady Gh Haddad, Issa F Khouri, Courtney D D DiNardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey Jorgensen, Monica Kwari, Susan O'Brien, Farhad Ravandi, Elias J Jabbour
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. American journal of hematology 98 (3) (2023)
Fadi G Haddad, Hagop M Kantarjian, Aram Bidikian, Elias J Jabbour, Nicholas James Short, Jing Ning, Lianchun Xiao, Naveen Pemmaraju, Courtney D D DiNardo, Tapan Mahendra Kadia, Kayleigh R Marx, Guillermo Garcia Manero, Farhad Ravandi, Koiji Sasaki, Ghayas C Issa
Association between bariatric surgery and outcomes in chronic myeloid leukemia. Cancer (2023)
Aram Bidikian, Elias J Jabbour, Ghayas C Issa, Nicholas James Short, Koiji Sasaki, Hagop M Kantarjian
Chronic myeloid leukemia without major molecular response after 2 years of treatment with tyrosine kinase inhibitor. American journal of hematology 98 (4) (2023)
Alex Bataller, Fadi G Haddad, Ghayas C Issa, Koiji Sasaki, Elias Jabbour, Gautam Borthakur, Alessandra Ferrajoli, Nicholas James Short
Sudden lymphoid blast crisis after tyrosine kinase inhibitor discontinuation in chronic phase chronic myeloid leukemia: cautionary tales for appropriate molecular monitoring. Leukemia & lymphoma 64 (3) (2023)
Guillermo Montalban Bravo, Rashmi Kanagal-Shamana, Ziyi Li, Danielle Hammond, Kelly Sharon Chien, Juan Jose Rodriguez-Sevilla, Koiji Sasaki, Elias Jabbour, Courtney DiNardo, Koichi Takahashi, Nicholas James Short, Ghayas C Issa, Naveen Pemmaraju, Tapan Kadia, Farhad Ravandi, Naval G Daver, Gautam Borthakur, Sanam Loghavi, Sherry Pierce, Carlos Bueso-Ramos, Hagop Kantarjian, Guillermo Garcia Manero
Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia. British journal of haematology (2023)
Curtis A Lachowiez, Sanam Loghavi, Zhihong Zeng, Tomoyuki Tanaka, Yi June Kim, Hidetaka Uryu, Sven Turkalj, Niels Asger Jakobsen, Marlise R Luskin, Dzifa Yawa Duose, Rebecca S Slack Tidwell, Nicholas James Short, Gautam Borthakur, Tapan Mahendra Kadia, Lucia Masarova, George D Tippett, Prithviraj Bose, Elias J Jabbour, Farhad Ravandi, Naval G Daver, Guillermo Garcia Manero, Hagop M Kantarjian, Jacqueline S Garcia, Paresh Vyas, Koichi Takahashi, Marina Y Konopleva, Courtney D D DiNardo
A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated myeloid malignancies. Blood cancer discovery (2023)
Danielle Hammond, Sanam Loghavi, Sa A Wang, Marina Y Konopleva, Tapan Mahendra Kadia, Naval G Daver, Maro Ohanian, Ghayas C Issa, Yesid Alvarado, Nicholas James Short, Koji Sasaki, Naveen Pemmaraju, Guillermo Montalban-Bravo, Curtis A Lachowiez, Abhishek Maiti, Guillermo Garcia Manero, Elias J Jabbour, Gautam Borthakur, Farhad Ravandi, Koichi Takahashi, Sherry R Pierce, Hagop M Kantarjian, Courtney D D DiNardo
Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents. Blood cancer journal 13 (1) (2023)
Jayastu Senapati, Muharrem Muftuoglu, Jo Ishizawa, Hussein A Abbas, Sanam Loghavi, Gautam Borthakur, Musa Ylimaz, Ghayas C Issa, Samuel I Dara, Mahesh Basyal, Li Li, Kiran Naqvi, Rasoul Pourebrahim, Elias J Jabbour, Steven Mitchell Kornblau, Nicholas James Short, Naveen Pemmaraju, Guillermo Garcia Manero, Farhad Ravandi, Joseph D Khoury, Naval G Daver, Hagop M Kantarjian, Michael Andreeff, Courtney D D DiNardo
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis. Blood cancer journal 13 (1) (2023)
Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Sanam Loghavi, Keyur P Patel, Guillermo Montalban Bravo, Lucia Masarova, Courtney D D DiNardo, Hagop M Kantarjian
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia. Cancer 129 (7) (2023)
Phillip A Thompson, Michael J Keating, Alessandra Ferrajoli, Nitin Jain, Christine B Peterson, Naveen Garg, Sa A Wang, Jeffrey L Jorgensen, Tapan Mahendra Kadia, Prithviraj Bose, Naveen Pemmaraju, Nicholas James Short, William G Wierda
Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRD. Leukemia (2023)
Hagop M Kantarjian, Nicholas James Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fady Gh Haddad, Issa F Khouri, Courtney D D DiNardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey Jorgensen, Monica Kwari, Susan O'Brien, Farhad Ravandi, Elias J Jabbour
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. American journal of hematology 98 (3) (2023)
Jayastu Senapati, Muharrem Muftuoglu, Jo Ishizawa, Hussein A Abbas, Sanam Loghavi, Gautam Borthakur, Musa Ylimaz, Ghayas C Issa, Samuel I Dara, Mahesh Basyal, Li Li, Kiran Naqvi, Rasoul Pourebrahim, Elias J Jabbour, Steven Mitchell Kornblau, Nicholas James Short, Naveen Pemmaraju, Guillermo Garcia Manero, Farhad Ravandi, Joseph D Khoury, Naval G Daver, Hagop M Kantarjian, Michael Andreeff, Courtney D D DiNardo
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis. Blood cancer journal 13 (1) (2023)
Nicholas James Short, Jayastu Senapati, Elias Jabbour
An Update on the Management of Advanced Phase Chronic Myeloid Leukemia. Current hematologic malignancy reports (2023)
Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Sanam Loghavi, Keyur P Patel, Guillermo Montalban Bravo, Lucia Masarova, Courtney D D DiNardo, Hagop M Kantarjian
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia. Cancer (2023)
Nicholas James Short, Elias J Jabbour, Walid Macaron, Farhad Ravandi, Nitin Jain, Rashmi Kanagal-Shamana, Keyur P Patel, Sanam Loghavi, Fady Gh Haddad, Musa Ylimaz, Ghayas C Issa, Partow Kebriaei, Steven M Kornblau, Sarah Pelletier, Wilmer Flores, Jairo Matthews, Rebecca Garris, Hagop M Kantarjian
Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT-PCR for BCR::ABL1. American journal of hematology (2023)
Fady Gh Haddad, Koiji Sasaki, Aram Bidikian, Ghayas C Issa, Tapan Mahendra Kadia, Nitin Jain, Yesid Alvarado, Nicholas James Short, Naveen Pemmaraju, Sanam Loghavi, Keyur P Patel, Rashmi Kanagal-Shamana, Musa Ylimaz, Lucia Masarova, Elias J Jabbour, Hagop M Kantarjian
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib era. American journal of hematology (2023)
Hagop M Kantarjian, Nicholas James Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fady Gh Haddad, Issa F Khouri, Courtney D D DiNardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey Jorgensen, Monica Kwari, Susan O'Brien, Farhad Ravandi, Elias J Jabbour
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. American journal of hematology (2023)
Elias J Jabbour, Fadi G Haddad, Nicholas James Short, Jayastu Senapati, Nitin Jain, Koiji Sasaki, Jeffrey L Jorgensen, Sa A Wang, Yesid Alvarado, Xuemei Wang, Courtney D D DiNardo, Lucia Masarova, Tapan M Kadia, Rebecca Garris, Farhad Ravandi, Hagop M Kantarjian
Phase II Study of Inotuzumab Ozogamicin for Measurable Residual Disease in Acute Lymphoblastic Leukemia in Remission. Blood (2023)
Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Sanam Loghavi, Keyur P Patel, Guillermo Montalban Bravo, Lucia Masarova, Courtney D D DiNardo, Hagop M Kantarjian
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia. Cancer 129 (7) (2023)
Nicholas James Short, Faustine Ong, Farhad Ravandi, Graciela Nogueras Gonzalez, Tapan M Kadia, Naval G Daver, Courtney D D DiNardo, Marina Y Konopleva, Gautam Borthakur, Betul Oran, Gheath Al-Atrash, Rohtesh S Mehta, Elias J Jabbour, Musa Yilmaz, Ghayas C Issa, Abhishek Maiti, Richard E Champlin, Hagop M Kantarjian, Elizabeth J Shpall, Uday R Popat
Impact of Type of Induction Therapy on Outcomes in Older Adults with AML after Allogeneic Stem Cell Transplantation. Blood advances (2023)
Aram Bidikian, Elias J Jabbour, Ghayas C Issa, Nicholas James Short, Koiji Sasaki, Hagop M Kantarjian
Chronic myeloid leukemia without major molecular response after 2 years of treatment with tyrosine kinase inhibitor. American journal of hematology 98 (4) (2023)
Alex Bataller, Alexandre Bazinet, Courtney D D DiNardo, Abhishek Maiti, Gautam Borthakur, Naval G Daver, Nicholas James Short, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Yilmaz, Guillermo Montalban-Bravo, Koichi Takahashi, Sanam Loghavi, Guillermo Garcia-Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan M Kadia
Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax. Blood advances (2023)
Aram Bidikian, Elias J Jabbour, Ghayas C Issa, Nicholas James Short, Koiji Sasaki, Hagop M Kantarjian
Chronic myeloid leukemia without major molecular response after 2 years of treatment with tyrosine kinase inhibitor. American journal of hematology (2023)
Alexandre Bazinet, Hagop M Kantarjian, Naszrin Arani, Uday Popat, Alex Bataller, Koiji Sasaki, Courtney D D DiNardo, Naval G Daver, Musa Ylimaz, Hussein A Abbas, Nicholas James Short, Ghayas C Issa, Elias J Jabbour, Sherry A Pierce, Julianne Chen, Ricky Garcia, Marina Konopleva, Guillermo Garcia Manero, Amin Alousi, Elizabeth J Shpall, Richard E Champlin, Gautam Borthakur, Farhad Ravandi, Tapan Mahendra Kadia
Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation. American journal of hematology (2023)
Jayastu Senapati, Warren C Fiskus, Naval G Daver, Nathaniel R Wilson, Farhad Ravandi, Guillermo Garcia Manero, Tapan Mahendra Kadia, Courtney D D DiNardo, Elias J Jabbour, Jan A Burger, Nicholas James Short, Yesid Alvarado, Nitin Jain, Lucia Masarova, Ghayas C Issa, Wei Qiao, Joseph D Khoury, Sherry Pierce, Darla Miller, Koiji Sasaki, Marina Y Konopleva, Kapil N Bhalla, Gautam Borthakur, Naveen Pemmaraju
Phase 1 Results of Bromodomain and Extraterminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Samuel Urrutia Argueta, Kelly Sharon Chien, Ziyi Li, Alex Bataller, Emmanuel Almanza, Koiji Sasaki, Guillermo Montalban Bravo, Nicholas James Short, Elias J Jabbour, Tapan Mahendra Kadia, Farhad Ravandi, Gautam Borthakur, Yesid Alvarado, Naval G Daver, Rashmi Kanagal-Shamana, Carlos Bueso-Ramos, Sherry A Pierce, Hagop M Kantarjian, Guillermo Garcia Manero
Performance of IPSS-M in patients with myelodysplastic syndrome after hypomethylating agent failure. American journal of hematology (2023)
Alex Bataller, Fadi G Haddad, Ghayas C Issa, Koiji Sasaki, Elias Jabbour, Gautam Borthakur, Alessandra Ferrajoli, Nicholas James Short
Sudden lymphoid blast crisis after tyrosine kinase inhibitor discontinuation in chronic phase chronic myeloid leukemia: cautionary tales for appropriate molecular monitoring. Leukemia & lymphoma (2023)
Daniel Nguyen, Hagop M Kantarjian, Nicholas James Short, Wei Qiao, Jing Ning, Branko Cuglievan, Naval G Daver, Courtney D D DiNardo, Elias J Jabbour, Tapan Mahendra Kadia, Gautam Borthakur, Guillermo Garcia Manero, Marina Y Konopleva, Michael Andreeff, Farhad Ravandi-Kashani, Koiji Sasaki, Ghayas C Issa
Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation. Cancer (2023)
Jayastu Senapati, Muharrem Muftuoglu, Jo Ishizawa, Hussein A Abbas, Sanam Loghavi, Gautam Borthakur, Musa Ylimaz, Ghayas C Issa, Samuel I Dara, Mahesh Basyal, Li Li, Kiran Naqvi, Rasoul Pourebrahim, Elias J Jabbour, Steven Mitchell Kornblau, Nicholas James Short, Naveen Pemmaraju, Guillermo Garcia Manero, Farhad Ravandi, Joseph D Khoury, Naval G Daver, Hagop M Kantarjian, Michael Andreeff, Courtney D D DiNardo
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis. Blood cancer journal 13 (1) (2023)
Nicholas James Short, Daniel Nguyen, Farhad Ravandi
Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitors. Blood cancer journal 13 (1) (2023)

Nicholas James Short.css-eqlu8i{font-size:small;padding-left:4px;} (Nicholas Short, Naval Daver, Nicholas J Short)

Publication Activity (10 Years)

Top Topics

Top Venues

Nicholas James Short (Nicholas Short, Naval Daver, Nicholas J Short)